Article
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non-Squamous Non-Small Cell Lung Cancer (Non-SQ NSCLC) Patients in Queensland, Australia From 2014-2023.
Thoracic cancer - 1 Apr 2026
Niranjan Navin, Guan Tracey, Niranjan Nitin, Taherian Fard Atefeh, Youlden Danny R, Mason Robert, Chan Bryan A, Sanmugarajah Jasotha
Abstract excerpt
BACKGROUND: Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most commonly mutated oncogene in solid tumors, detected in up to 30% of lung adenocarcinomas. This study aimed to address gaps in the literature by analyzing KRAS mutations (KRASM) in a large Australian population. METHODS: A total of 3982 patients with metastatic nonsquamous nonsmall cell lung cancer diagnosed via public hospitals were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.